Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

NS21: re-defined and modified supplement B27 for neuronal cultures.

Journal of neuroscience methods | 2008

In vitro culturing of primary neurons is a mainstay of neurobiological research. Many of these culture paradigms have taken advantage of defined culture media rather than serum additives that contain undefined survival factors to facilitate experimental manipulations and interpretation of the results. To culture neurons in the absence of serum, defined supplements such as B27 are now widely used. However, commercially available supplements exhibit large variability in their capabilities to support neurons in culture. We re-optimized and modified earlier published formulations of B27 using 21 different ingredients (NS21). NS21 supports neuronal cultures of high quality as manifested by their morphological characteristics, formation of synapses, and postsynaptic responses. Much of the variability in the quality of B27/NS21 was due to variability in the quality of different sources of bovine serum albumin. Furthermore, we found that holo-transferrin used in NS21 is preferable over apo-transferrin used in B27 for the quality of neuronal cultures.

Pubmed ID: 18471889 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG013730-06
  • Agency: NINDS NIH HHS, United States
    Id: NS035563
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS046450
  • Agency: NIDA NIH HHS, United States
    Id: DA15043
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA015043
  • Agency: NIA NIH HHS, United States
    Id: AG017502
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS046450-04
  • Agency: NIA NIH HHS, United States
    Id: R01 AG017502-06A1
  • Agency: NIA NIH HHS, United States
    Id: R01 AG017502
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS039358-06
  • Agency: NIA NIH HHS, United States
    Id: R56 AG017502
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA015043-06
  • Agency: NIA NIH HHS, United States
    Id: AG013730
  • Agency: NINDS NIH HHS, United States
    Id: NS039358
  • Agency: NIA NIH HHS, United States
    Id: RF1 AG013730
  • Agency: NIA NIH HHS, United States
    Id: R01 AG013730
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS035563
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS039358
  • Agency: NINDS NIH HHS, United States
    Id: NS046450
  • Agency: NIDA NIH HHS, United States
    Id: R37 DA015043
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS035563-06
  • Agency: NIA NIH HHS, United States
    Id: R56 AG013730

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Charles River Laboratories (tool)

RRID:SCR_003792

Commercial organism provider selling mice, rats and other model animals. American corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. (Wikipedia)

View all literature mentions